✦ LIBER ✦

Binding of a highly potent protease-activated receptor-2 (PAR2) activating peptide, [3H]2-furoyl-LIGRL-NH2, to human PAR2

✍ Scribed by Toru Kanke; Hiroyuki Ishiwata; Mototsugu Kabeya; Masako Saka; Takeshi Doi; Yukio Hattori; Atsufumi Kawabata; Robin Plevin

Book ID: 110008702
Publisher: Nature Publishing Group
Year: 2005
Tongue: English
Weight: 205 KB
Volume: 145
Category: Article
ISSN: 0007-1188
DOI: 10.1038/sj.bjp.0706189

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A protease activated receptor-2 (PAR-2)

A protease activated receptor-2 (PAR-2) activating peptide, tc-LIGRLO-NH2, induces protease release from mast cells: role in TNF degradation

✍ Hashem N Alshurafa; Grant R Stenton; John L Wallace; Morley D Hollenberg; A Dean 📂 Article 📅 2004 🏛 BioMed Central 🌐 English ⚖ 792 KB

## Background Mast cell (MC)-derived serine proteases have been implicated in a variety of inflammatory processes. We have previously shown that rat peritoneal MC (PMC) express mRNA for protease activated receptor 2 (PAR-2), a G-coupled receptor activated by trypsin-like proteases. Recent evidence

Exogeneous Chitinases Activate and Induc

Exogeneous Chitinases Activate and Induce Degranulation of Human Eosinophils through a Protease-Activated Receptor-2 (PAR-2)

✍ Matsuwaki, Y.; Thomas, W.; Hotta, K.; Kita, H. 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 185 KB

Protease-Activated Receptor-2 (PAR-2): S

Protease-Activated Receptor-2 (PAR-2): Structure-Function Study of Receptor Activation by Diverse Peptides Related to Tethered-Ligand Epitopes

✍ Bruce E. Maryanoff; Rosemary J. Santulli; David F. McComsey; William J. Hoekstra 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 110 KB

The C-terminus of murine S100A9 protein

The C-terminus of murine S100A9 protein inhibits hyperalgesia induced by the agonist peptide of protease-activated receptor 2 (PAR2)

✍ C S Dale; N Cenac; L R G Britto; M A Juliano; L Juliano; N Vergnolle; R Giorgi 📂 Article 📅 2006 🏛 Nature Publishing Group 🌐 English ⚖ 187 KB

Pharmacological Characterization of MK-0

Pharmacological Characterization of MK-0974 [N-[(3R,6S)-6-(2,3-Difluorophenyl)-2-oxo-1-(2,2,2-trifluoroethyl)azepan-3-yl]-4-(2-oxo-2,3-dihydro-1H-imidazo[4,5-b]pyridin-1-yl)piperidine-1-carboxamide], a Potent and Orally Active Calcitonin Gene-Related Peptide Receptor Antagonist for the Treatment of Migraine

✍ Salvatore, C. A.; Hershey, J. C.; Corcoran, H. A.; Fay, J. F.; Johnston, V. K.; 📂 Article 📅 2007 🏛 American Society for Pharmacology and Experimental 🌐 English ⚖ 370 KB

A57. Factor VIIa protects human endothel

A57. Factor VIIa protects human endothelial cells from hydrogen peroxide-induced cell death through its binding of tissue factor and activation of PAR-2 receptors

✍ Rong Jiang; Ning-Ping Wang; Amanda J. Zatta; James G. Reeves; James Mykytenko; Z 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 56 KB